Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

GlaxoSmithKline plc

BioPhotonics
Aug 2007
GlaxoSmithKline plc of Brentford, UK, Imperial College London and the Medical Research Council, also of London, have established the Clinical Imaging Centre in the same city. Contributing a total of £83 million, the institutions created the center to facilitate the development of medicines for cancer, cardiovascular disease and neurological disorders through the use of MRI and PET. Housing a radiochemistry development facility, two MRI devices and two PET scanners, the unit will have the ability to perform 2500 scans per year. Research fellows from the college as well as clinical, scientific and support staff will work on the building’s three floors. GlaxoSmithKline has pledged to invest £11 million in the center for each of the next 10 years.

Basic ScienceBiophotonicsGlaxoSmithKline plcMRINews & FeaturesPET

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.